Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
Dare to Achieve Genome & Company
2022

Share:

Dare to Achieve Genome & Company

Corporate identity

Genome & Company is a clinical-stage biotechnology company based in Korea. Their research and development program focuses on microbiome-based products. However, they have also invested in the immuno-oncology microbiome and positioned themselves to ensure people's right to health, creating possibilities for treatment beyond existing medical treatments. The company strives to create a world where microbiomes can be more accessible to even ordinary people. The design renders a microbiome world in an artistic manner through the use of hand-made brushstrokes that convey the organic quality of the products. The goal is to position Genome & Company as more than just another scientific biotechnology company but rather a friendly entity.

Client / Manufacturer

Genome & Company

Gyeonggi-do, KR
Design
Interbrand Seoul

Interbrand Seoul

Seoul, KR

Genome & Company

Gyeonggi-do, KR
Date of Launch
2021
Development Time
up to 12 months
Target Regions
Specific country/region: Research centers and tertiary hospitals in South Korea and pharmaceutical companies globally.
Target Groups
Other target groups: Immuno-onclogy focused Research & Development, Pharmaceuticals, Cosmeceuticals, Dietary Supplements

RELATED PROJECTS